Doxycycline and minocycline act as positive allosteric modulators of the PAC1 receptor and induce plasminogen activators in RT4 schwann cells
- Publisher:
- MDPI AG
- Publication Type:
- Journal Article
- Citation:
- Applied Sciences (Switzerland), 2021, 11, (16), pp. 7673-7673
- Issue Date:
- 2021-08-02
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
Regeneration of peripheral nerves depends on the ability of axons to navigate through an altered extracellular environment. It has been suggested that Schwann cells facilitate this process through their secretion of neuropeptides and proteases. Using the RT4‐D6P2T Schwann cell line (RT4), we have previously shown that RT4 cultures endogenously express the neuropeptide PACAP, and respond to exogenous stimulation by inducing the expression of tissue plasminogen activator (tPA) and urokinase plasminogen activator (uPA) via PAC1 receptor activation. In this study, based on recent findings showing that doxycycline and minocycline act as positive allosteric modulators (PAMs) of the PAC1 receptor, we tested if treatment with these tetracyclines induced the expression and activity of tPA and uPA in RT4 cells. Using ELISA and zymographic analyses, we demonstrate that doxycycline and minocycline reliably induce the secretion and activity of both tPA and uPA, which is paralleled by increased expression levels, as shown by immunocytochemistry and Western blots. These actions were mediated, at least in part, by the PAC1 receptor, as PACAP6‐38 mitigated tetracycline‐induced expression and activity of tPA and uPA. We conclude that doxycycline and minocycline act as PAMs of the PAC1 receptor to promote proteolytic activity in RT4 cells.
Please use this identifier to cite or link to this item: